Status:
COMPLETED
Study Evaluating the Safety of Enbrel (Etanercept)
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Arthritis, Psoriatic
Eligibility:
All Genders
Brief Summary
The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.
Eligibility Criteria
Inclusion
- All patients from the study center who received or will receive at least one dose of Enbrel according to the approved product indication.
Exclusion
- Previously discontinued Enbrel therapy due to significant safety concern.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT00683384
Start Date
January 1 2007
End Date
October 1 2009
Last Update
November 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metro Manila, Philippines